Ignite Creation Date:
2024-05-06 @ 3:49 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04766619
Status:
UNKNOWN
Last Update Posted:
2021-02-23
First Post:
2021-01-25
Brief Title:
Process Evaluation of OptimiseRx and PINCER
Sponsor:
University of Nottingham
Organization:
University of Nottingham
Study Overview
Official Title:
Generating Recommendations for National Roll-out and Sustainable Use of Prescribing Safety Indicator Based Interventions Using Longitudinal Process Evaluation and a Consolidated Learning Exercise
Status:
UNKNOWN
Status Verified Date:
2021-02
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to evaluate two interventions designed to make medication prescribing safer OptimiseRx and PINCER which are being used in general practices across England The findings from the evaluation will be used to generate recommendations as to how these interventions can be used sustainably in the long-term
Detailed Description:
This study has been designed to evaluate and gain an understanding of the real world implementation fidelity and medium and longer-term embedding and sustainability of two prescribing safety interventions the computerised decision support CDS tool - Optimize Rx and PINCER pharmacist-led information technology intervention for reducing clinically important errors in medication management The longitudinal process evaluation will involve observations interviews focus groups and questionnaires The consolidated learning exercise which aims to inform long-term sustainable intervention use will involve a documentary analysis interviews focus groups development workshops and a synthesis of the evaluation results
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None